Last 12 months
Inside the activity.
4 purchase rows · 41 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 12 |
| Dec 2025 | 0 | 18 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 0 |
| May 2026 | 3 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2017 Filed Mar 31, 2017 20:39 UTC |
Hunsaker Craig ESee Remarks
|
GrantWarrants (right to buy) · Derivative | 250,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0000899243-17-009012 · doc4.xml · derivative · entry 2 Hunsaker Craig E · CIK 0001509282 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires not disclosed F2 · derivative.exercise_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. F2 · derivative.expiration_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:39 UTC |
Hunsaker Craig ESee Remarks
|
GrantSeries A Convertible Preferred Stock · Derivative | 500 | $1,000.00 Strike: $2.00 | $500,000.00 |
DisclosureSEC source: 0000899243-17-009012 · doc4.xml · derivative · entry 1 Hunsaker Craig E · CIK 0001509282 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 250,000 shares Expires not disclosed F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:41 UTC |
Berkowitz Mortimer IIIDirector
|
GrantWarrants (right to buy) · Derivative | 200,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0000899243-17-009014 · doc4.xml · derivative · entry 4 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Porcupine Investment Partners, LLC Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires not disclosed F2 · derivative.exercise_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. F2 · derivative.expiration_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:41 UTC |
Berkowitz Mortimer IIIDirector
|
GrantWarrants (right to buy) · Derivative | 200,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0000899243-17-009014 · doc4.xml · derivative · entry 3 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires not disclosed F2 · derivative.exercise_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. F2 · derivative.expiration_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:41 UTC |
Berkowitz Mortimer IIIDirector
|
GrantSeries A Convertible Preferred Stock · Derivative | 400 | $1,000.00 Strike: $2.00 | $400,000.00 |
DisclosureSEC source: 0000899243-17-009014 · doc4.xml · derivative · entry 2 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Porcupine Investment Partners, LLC Disclosed balance after: 400 Underlying: Common Stock · 200,000 shares Expires not disclosed F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:41 UTC |
Berkowitz Mortimer IIIDirector
|
GrantSeries A Convertible Preferred Stock · Derivative | 400 | $1,000.00 Strike: $2.00 | $400,000.00 |
DisclosureSEC source: 0000899243-17-009014 · doc4.xml · derivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Common Stock · 200,000 shares Expires not disclosed F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:40 UTC |
Snider BrianSee Remarks
|
GrantWarrants (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0000899243-17-009013 · doc4.xml · derivative · entry 4 Snider Brian · CIK 0001702383 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F5 · derivative.exercise_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. F5 · derivative.expiration_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:40 UTC |
Snider BrianSee Remarks
|
GrantSeries A Convertible Preferred Stock · Derivative | 100 | $1,000.00 Strike: $2.00 | $100,000.00 |
DisclosureSEC source: 0000899243-17-009013 · doc4.xml · derivative · entry 3 Snider Brian · CIK 0001702383 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 Underlying: Common Stock · 50,000 shares Expires not disclosed F4 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. F4 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:39 UTC |
Allen JonathanSee Remarks
|
GrantWarrants (right to buy) · Derivative | 125,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0000899243-17-009008 · doc4.xml · derivative · entry 2 Allen Jonathan · CIK 0001700477 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires not disclosed F2 · derivative.exercise_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. F2 · derivative.expiration_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:39 UTC |
Allen JonathanSee Remarks
|
GrantSeries A Convertible Preferred Stock · Derivative | 250 | $1,000.00 Strike: $2.00 | $250,000.00 |
DisclosureSEC source: 0000899243-17-009008 · doc4.xml · derivative · entry 1 Allen Jonathan · CIK 0001700477 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 125,000 shares Expires not disclosed F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. Read SEC document |
| March 20, 2017 Filed Mar 31, 2017 20:40 UTC |
Snider BrianSee Remarks
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $2.87 | $0.00 |
DisclosureSEC source: 0000899243-17-009013 · doc4.xml · derivative · entry 2 Snider Brian · CIK 0001702383 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2027-03-19 F3 · derivative.exercise_date: The options vest over four years with 25% vesting on the anniversary of the grant date and the remaining 75% vesting in 36 installments every month for the three years thereafter. Read SEC document |
| March 06, 2017 Filed Mar 15, 2017 20:20 UTC |
Black Jeffrey G.Executive VP & CFO
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0000899243-17-007671 · doc4.xml · derivative · entry 1 Black Jeffrey G. · CIK 0001449439 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2027-03-05 F1 · derivative.exercise_date: The options vest over four years with 25% vesting on the anniversary of the grant date and the remaining 75% vesting in 36 installments every month for the three years thereafter. Read SEC document |
| February 21, 2017 Filed May 3, 2017 14:02 UTC |
CROSS LESLIE HDirector
|
GrantNQ Stock Option · Derivative | 5,208 | $3.09 Strike: $3.09 | $16,092.72 |
DisclosureSEC source: 0001179110-17-006461 · edgar.xml · derivative · entry 1 CROSS LESLIE H · CIK 0001248189 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,208 Underlying: Common Stock · 5,208 shares Expires 2027-02-21 F1 · derivative.exercise_date: The options will vest 25% on the first anniversary of the grant date and 1/12th of the shares vest every 3 months thereafter. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 23:14 UTC |
Rich Terry M.Director · Chief Executive Officer
|
PurchaseCommon Stock | 2,500 | $4.26 | $10,660.00 |
DisclosureSEC source: 0001350653-16-000128 · wf-form4_148218923626380.xml · nonDerivative · entry 1 Rich Terry · CIK 0001544482 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,500 Read SEC document |
| December 16, 2016 Filed Dec 20, 2016 20:24 UTC |
CROSS LESLIE HDirector
|
PurchaseCommon Sock | 15,000 | $4.25 | $63,795.00 |
DisclosureSEC source: 0001350653-16-000129 · wf-form4_148228347487897.xml · nonDerivative · entry 1 CROSS LESLIE H · CIK 0001248189 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,443 Read SEC document |
| December 12, 2016 Filed Dec 16, 2016 13:17 UTC |
Plunkett Michael JosephPresident and COO
|
GrantIncentive Stock Option · Derivative | 25,000 | $4.35 Strike: $4.43 | $108,750.00 |
DisclosureSEC source: 0001350653-16-000125 · wf-form4_148191222124805.xml · derivative · entry 2 Plunkett Michael Joseph · CIK 0001492279 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,750 Underlying: Common Sock · 25,000 shares Expires 2026-12-12 F5 · price: The exercise price per share. F4 · derivative.exercise_date: The options vest over four years with 25% vesting on November 8, 2016 and the remainder vesting in 36 installments each month thereafter. Read SEC document |
| December 12, 2016 Filed Dec 16, 2016 13:17 UTC |
Plunkett Michael JosephPresident and COO
|
GrantCommon Stock - Restricted Stock Units | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001350653-16-000125 · wf-form4_148191222124805.xml · nonDerivative · entry 1 Plunkett Michael Joseph · CIK 0001492279 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,961 F1 · security: The RSUs vest over four years. 25% of the RSUs vest annually on the anniversary of the grant date and 25% vest on each anniversary thereafter. F2 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. F3 · balance_after: Does not include performance-based restricted stock units, if any, held by the Reporting Person for which an assessment has not yet been made regarding the achievement of the applicable performance goals. Read SEC document |
| December 12, 2016 Filed Dec 16, 2016 13:15 UTC |
CROSS LESLIE HDirector
|
GrantNQ Stock Option · Derivative | 7,751 | $4.43 Strike: $4.43 | $34,336.93 |
DisclosureSEC source: 0001350653-16-000120 · wf-form4_148191211310081.xml · derivative · entry 2 CROSS LESLIE H · CIK 0001248189 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,794 Underlying: Common Stock · 7,751 shares Expires 2026-12-12 F2 · shares: The options are fully vested as of the grant date. F3 · price: The exercise price per share. Read SEC document |
| December 12, 2016 Filed Dec 16, 2016 13:16 UTC |
MARSHALL SIRI SDirector
|
GrantNQ Stock Option · Derivative | 14,610 | $4.43 Strike: $4.43 | $64,722.30 |
DisclosureSEC source: 0001350653-16-000122 · wf-form4_148191216110643.xml · derivative · entry 2 MARSHALL SIRI S · CIK 0001206689 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,221 Underlying: Common Stock · 14,610 shares Expires 2026-12-12 F2 · price: Exercise price per share. F1 · derivative.exercise_date: The options are fully vested as of the grant date. Read SEC document |
| December 12, 2016 Filed Dec 16, 2016 18:17 UTC |
Garner EbunGeneral Counsel and SVP
|
GrantIncentive Stock Option · Derivative | 40,000 | $4.43 Strike: $4.43 | $177,200.00 |
DisclosureSEC source: 0001350653-16-000127 · wf-form4_148191225949573.xml · derivative · entry 2 Garner Ebun · CIK 0001364554 · General Counsel and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,514 Underlying: Common Stock · 40,000 shares Expires 2026-12-12 F5 · price: Exercise price per share. F4 · derivative.exercise_date: The options vest over four years with 25% vesting on the anniversary of the grant date and the remainder vesting in 36 installments each month thereafter. Read SEC document |
| December 12, 2016 Filed Dec 16, 2016 18:17 UTC |
Garner EbunGeneral Counsel and SVP
|
GrantCommon Stock - Restricted Stock Units | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001350653-16-000127 · wf-form4_148191225949573.xml · nonDerivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,545 F1 · security: The RSUs vest annually with 25% vesting on the anniversary of the grant date, and 25% vesting each anniversary thereafter. F2 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. F3 · balance_after: Does not include performance-based restricted stock units, if any, held by the Reporting Person for which an assessment has not yet been made regarding the achievement of the applicable performance goals. Read SEC document |
| December 12, 2016 Filed Dec 16, 2016 18:17 UTC |
Nelson DennisVP, Finance and Controller
|
GrantIncentive Stock Option · Derivative | 15,000 | $4.43 Strike: $4.43 | $66,450.00 |
DisclosureSEC source: 0001350653-16-000126 · wf-form4_148191224332191.xml · derivative · entry 2 Nelson Dennis · CIK 0001504126 · VP, Finance and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Sock · 15,000 shares Expires 2026-12-12 F5 · price: The exercise price per share. F4 · derivative.exercise_date: The options vest over four years with 25% vesting on the anniversary of the grant date and the remainder vesting in 36 installments each month thereafter. Read SEC document |
| December 12, 2016 Filed Dec 16, 2016 18:17 UTC |
Nelson DennisVP, Finance and Controller
|
GrantCommon Stock - Restricted Stock Units | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001350653-16-000126 · wf-form4_148191224332191.xml · nonDerivative · entry 1 Nelson Dennis · CIK 0001504126 · VP, Finance and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,497 F1 · security: The RSUs vest over four years with 25% vesting on the anniversary of the grant date, and 25% vesting each anniversary thereafter, subject to continued service on each vesting date. F2 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. F3 · balance_after: Does not include performance-based restricted stock units, if any, held by the Reporting Person for which an assessment has not yet been made regarding the achievement of the applicable performance goals. Read SEC document |
| December 12, 2016 Filed Dec 16, 2016 18:16 UTC |
Williams Donald AllenDirector
|
GrantNQ Stock Option · Derivative | 3,303 | $4.43 Strike: $4.43 | $14,632.29 |
DisclosureSEC source: 0001350653-16-000123 · wf-form4_148191217752978.xml · derivative · entry 2 Williams Donald Allen · CIK 0001620013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,569 Underlying: Common Sock · 3,303 shares Expires 2026-12-12 F2 · price: The exercise price per share. F1 · derivative.exercise_date: The options are fully vested as of the grant date. Read SEC document |
| December 12, 2016 Filed Dec 16, 2016 18:16 UTC |
Oneil StephenDirector
|
GrantNQ Stock Option · Derivative | 14,610 | $4.43 Strike: $4.43 | $64,722.30 |
DisclosureSEC source: 0001350653-16-000124 · wf-form4_148191220135691.xml · derivative · entry 2 Oneil Stephen · CIK 0001364564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,221 Underlying: Common Stock · 14,610 shares Expires 2026-12-12 F2 · price: Exercise price per share. F1 · derivative.exercise_date: The options are fully vested as of the grant date. Read SEC document |
| December 12, 2016 Filed Dec 16, 2016 18:15 UTC |
Molson R IanDirector
|
GrantNQ Stock Option · Derivative | 16,324 | $4.43 Strike: $4.43 | $72,315.32 |
DisclosureSEC source: 0001350653-16-000121 · wf-form4_148191214241717.xml · derivative · entry 3 Molson R Ian · CIK 0001364553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,025 Underlying: Common Stock · 16,324 shares Expires 2026-12-12 F3 · price: Exercise Price Per Share F2 · derivative.exercise_date: The options are fully vested as of the grant date. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 01:40 UTC |
Foster John10% owner
|
SaleCommon Stock | 1,033 | $5.25 | $5,423.25 |
DisclosureSEC source: 0000899243-16-034745 · doc4.xml · nonDerivative · entry 4 Foster John · CIK 0001364631 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · ownership.direct: On November 29, 2016 and November 30, 2016, 2,600 shares and 12,400 shares, respectively, held by John H. Foster were sold and, on November 29, 2016 and November 30, 2016, 1,500 shares and 1,033 shares, respectively, held by John H. Foster, trustee u/w of Virginia C. Foster, were sold. Mr. Foster is a trustee and the principal beneficiary of such trust. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 01:40 UTC |
Foster John10% owner
|
SaleCommon Stock | 12,400 | $5.22 | $64,728.00 |
DisclosureSEC source: 0000899243-16-034745 · doc4.xml · nonDerivative · entry 3 Foster John · CIK 0001364631 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,033 F1 · ownership.direct: On November 29, 2016 and November 30, 2016, 2,600 shares and 12,400 shares, respectively, held by John H. Foster were sold and, on November 29, 2016 and November 30, 2016, 1,500 shares and 1,033 shares, respectively, held by John H. Foster, trustee u/w of Virginia C. Foster, were sold. Mr. Foster is a trustee and the principal beneficiary of such trust. Read SEC document |
| November 29, 2016 Filed Dec 2, 2016 01:40 UTC |
Foster John10% owner
|
SaleCommon Stock | 1,500 | $5.37 | $8,055.00 |
DisclosureSEC source: 0000899243-16-034745 · doc4.xml · nonDerivative · entry 2 Foster John · CIK 0001364631 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,433 F1 · ownership.direct: On November 29, 2016 and November 30, 2016, 2,600 shares and 12,400 shares, respectively, held by John H. Foster were sold and, on November 29, 2016 and November 30, 2016, 1,500 shares and 1,033 shares, respectively, held by John H. Foster, trustee u/w of Virginia C. Foster, were sold. Mr. Foster is a trustee and the principal beneficiary of such trust. Read SEC document |
| November 29, 2016 Filed Dec 2, 2016 01:40 UTC |
Foster John10% owner
|
SaleCommon Stock | 2,600 | $5.37 | $13,962.00 |
DisclosureSEC source: 0000899243-16-034745 · doc4.xml · nonDerivative · entry 1 Foster John · CIK 0001364631 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,933 F1 · ownership.direct: On November 29, 2016 and November 30, 2016, 2,600 shares and 12,400 shares, respectively, held by John H. Foster were sold and, on November 29, 2016 and November 30, 2016, 1,500 shares and 1,033 shares, respectively, held by John H. Foster, trustee u/w of Virginia C. Foster, were sold. Mr. Foster is a trustee and the principal beneficiary of such trust. Read SEC document |
| November 15, 2016 Filed Nov 18, 2016 17:13 UTC |
Plunkett Michael JosephPresident and COO
|
OtherCommon Stock | 2,486 | $1.94 | $4,817.87 |
DisclosureSEC source: 0001350653-16-000115 · wf-form4_147950720010901.xml · nonDerivative · entry 1 Plunkett Michael Joseph · CIK 0001492279 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,682 F1 · kind: The shares were purchased from the issuer pursuant to the issuer's 2007 Employee Stock Purchase Plan. F1 · price: The shares were purchased from the issuer pursuant to the issuer's 2007 Employee Stock Purchase Plan. F2 · balance_after: Does not include performance-based restricted stock units, if any, held by the Reporting Person for which an assessment has not yet been made regarding the achievement of the applicable performance goals. Read SEC document |
| November 15, 2016 Filed Nov 18, 2016 22:14 UTC |
Garner EbunGeneral Counsel and SVP
|
OtherCommon Stock | 322 | $1.94 | $624.04 |
DisclosureSEC source: 0001350653-16-000116 · wf-form4_147950727529781.xml · nonDerivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,250 F1 · kind: The shares were purchased from the issuer pursuant to the issuer's 2007 Employee Stock Purchase Plan. F1 · price: The shares were purchased from the issuer pursuant to the issuer's 2007 Employee Stock Purchase Plan. F2 · balance_after: Does not include performance-based restricted stock units, if any, held by the Reporting Person for which an assessment has not yet been made regarding the achievement of the applicable performance goals. Read SEC document |
| November 15, 2016 Filed Dec 16, 2016 13:14 UTC Amendment |
Plunkett Michael JosephPresident and COO
|
OtherCommon Stock - Restricted Stock Units | 2,486 | $1.94 | $4,817.87 |
DisclosureSEC source: 0001350653-16-000117 · wf-form4a_148191206016891.xml · nonDerivative · entry 1 Plunkett Michael Joseph · CIK 0001492279 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,961 F1 · kind: The shares were purchased from the issuer pursuant to the issuer's 2007 Employee Stock Purchase Plan. F1 · price: The shares were purchased from the issuer pursuant to the issuer's 2007 Employee Stock Purchase Plan. F2 · balance_after: Does not include performance-based restricted stock units, if any, held by the Reporting Person for which an assessment has not yet been made regarding the achievement of the applicable performance goals. F3 · balance_after: This amount was incorrectly listed as 18,682 in the original Form 4. Read SEC document |
| November 15, 2016 Filed Dec 16, 2016 18:14 UTC Amendment |
Garner EbunGeneral Counsel and SVP
|
OtherCommon Stock | 322 | $1.94 | $624.04 |
DisclosureSEC source: 0001350653-16-000118 · wf-form4a_148191207664218.xml · nonDerivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,545 F1 · kind: The shares were purchased from the issuer pursuant to the issuer's 2007 Employee Stock Purchase Plan. F1 · price: The shares were purchased from the issuer pursuant to the issuer's 2007 Employee Stock Purchase Plan. F2 · balance_after: Does not include performance-based restricted stock units, if any, held by the Reporting Person for which an assessment has not yet been made regarding the achievement of the applicable performance goals. F3 · balance_after: This amount was incorrectly listed as 8,250 in the original Form 4 filing. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.